Abstract:Introduction Monoclonal antibodies (mAbs) play a pivotal role in disease diagnosis as well as immunotherapy interventions. Traditional monoclonal antibody generation relies on animal immunization procedures predominantly involving mice; however, recent advances in in-vitro expression methodologies have enabled large-scale production suitable for both industrial applications as well as scientific investigations. Methods In this study, two mAbs against H7 subtype avian influenza viruses (AIV) were sequenced and analyzed, and the DNA sequences encoding heavy chain (HC) and light chain (LC) were obtained and cloned into pCHO-1.0 expression vector. Then, the HC and LC expression plasmids were transfected into CHO-S cells to establish stable cell lines expressing these mAbs using a two-phase selection scheme with different concentrations of methotrexate and puromycin. Recombinant antibodies were purified from the cell culture medium, and their potential applications were evaluated using hemagglutination inhibition (HI), western blotting (WB), confocal microscopy, and enzyme-linked immunosorbent assay (ELISA). Results The results indicated that the obtained recombinant antibodies exhibited biological activity similar to that of the parent antibodies derived from ascites and could be used as a replacement for animal-derived mAbs. A kinetic analysis of the two antibodies to the AIV HA protein, conducted using surface plasmon resonance (SPR), showed concordance between the recombinant and parental antibodies. Discussion The data presented in this study suggest that the described antibody production protocol could avoid the use of experimental animals and better conform to animal welfare regulations, and provides a basis for further research and development of mAbs-based diagnostic products.

The Preparation and Identification of Monoclonal Antibodies Against Avian Paramyxovirus Type2

Preparation of Monoclonal Antibodies against Cucumber Green Mottle Mosaic Virus

Preparation and Identification of Monoclonal Antibodies Against M Protein of Avian Infectious Bronchitis Virus

Expression and Immunogenic Comparison of VP2 and VP3 from Marine Birnavirus

Preparation and Characterization of Monoclonal Antibody Against M Protein of Dengue Virus Serotype 2

Preparation of monoclonal antibodies against Yamagata-lineage influenza B virus hemagglutinin protein and establishment of a dual antibody sandwich ELISA detection method

Development of monoclonal antibodies against Marek's disease virus

[Preparation and primary analysis of monoclonal antibodies against VP5 protein of chicken infectious bursal disease virus]

Development and characterization of a novel specific monoclonal antibody against mink enteritis virus and its antigen epitope analysis

Expression and characterization of recombinant antibodies against H7 subtype avian influenza virus and their diagnostic potential

[The Preparation of Monoclonal Antibodies Against AAV2 and Study on Their Characterizations].

Preparation of the Monoclonal Antibody Specific to Mig-2 Protein by Genetic Immunization

Development of an Antigen-Capture Enzyme-Linked Immunosorbent Assay and Immunochromatographic Strip Based on Monoclonal Antibodies for Detection of H6 Avian Influenza Viruses

Preparation and Identification of Monoclonal Antibodies Against the Adenovirus Vector

Preparation of ChIL-2 and IBDV VP2 Fusion Protein by Baculovirus Expression System

Preparation and identification of monoclonal antibodies against locale isolated strain of duck hepatitis virus

Preparation of a new monoclonal antibody against subgroup A of avian leukosis virus and identifying its antigenic epitope

Preparation and Antigenic Site Identification of Monoclonal Antibodies against PB1 Protein of H9N2 Subtype AIV

Preparation and Identification of Monoclonal Antibody Against Nonstructural Protein 3D of Foot-and-mouth Disease Virus

Preparation of the Monoclonal Antibody Against Swine IgG

Identification and primary application of hybridomas cell secreting monoclonal antibodies against mink (Neovison vison) interferon-gamma